News

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...
Most people with prediabetes don’t have any symptoms, but darkened skin, skin tags and changes in the eyes could be ...
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...
Indian pharmaceutical companies are preparing to flood the market with generic versions of Novo Nordisk’s semaglutide—sold ...
"I’m sure someone’s lost their job," said the CEO of Sandoz, which has now filed to launch a generic GLP-1 in Canada next ...
FROM nausea to constipation and life-threatening pancreatitis, fat jabs come with a long list of possible side effects. But, ...
A one-off weight-loss treatment that has been around since the 1950s is far superior than drugs like Ozempic when it comes to ...
When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
WEIGHT loss jabs, including Mounjaro and Wegovy, have been linked to more than 100 deaths in the UK, new figures have revealed. But none of the fatalities are proven to have been caused directly ...
A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to ...